The University of Chicago Header Logo

Connection

Daniel Shevrin to Drug Resistance

This is a "connection" page, showing publications Daniel Shevrin has written about Drug Resistance.
Connection Strength

0.028
  1. Phase II trial of echinomycin in advanced hormone-resistant prostate cancer. An Illinois Cancer Council study. Invest New Drugs. 1994; 12(1):65-6.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.